Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

The GRASP trial has completed recruitment and will now begin its follow up phase.

GRASP logo

The GRASP trial is looking at the best ways to treat shoulder pain in people with a rotator cuff disorder. We are testing two different types of physiotherapy treatment pathways routinely used to treat people with rotator cuff problems. The study is also investigating whether a corticosteroid injection in the shoulder joint before starting physiotherapy helps relieve pain and improve patient function more quickly.

Since early 2017, 708 participants have been enrolled into the GRASP trial across 20 NHS Hospital Trusts in England. We have now finished the recruitment part of this study. Over the next 12 months we will be asking participants to complete questionnaires at 8 weeks, 6 and 12 months after they first entered into the study asking them about how their health, activity and shoulder pain. The trial results are anticipated in the summer/autumn of 2020.

We are very grateful to all of the patients who are taking part in the GRASP trial and to the clinical and research staff at our participating NHS Hospital Trust’s (

GRASP is funded by the National Institute for Health Research Health Technology Assessment Programme (ID: 15/26/06).

Similar stories

Adalimumab is found to be a cost-effective treatment for early-stage Dupuytren’s disease

Researchers at the Kennedy Institute of Rheumatology and Oxford Population Health’s Health Economics Research Centre have found that anti-TNF treatment (adalimumab) is likely to be a cost-effective treatment for people affected by early-stage Dupuytren’s disease.

Three NIHR HTA grants awarded to Professor Tim Theologis

Congratulations to Professor Tim Theologis, who has been awarded three NIHR HTA grants to extend research in orthopaedic disorders in children.

Going straight to surgery found to be better than undergoing rehabilitation first for longstanding anterior cruciate ligament injury

New research, funded by the National Institute for Health and Care Research (NIHR), shows initial surgery to be more successful and cost effective than undergoing treatment with rehabilitation first to treat longstanding anterior cruciate ligament injury.

Oxford receives NIHR funding to test anti-TNF on post operative delirium

Researchers at the University of Oxford have been awarded a grant from the National Institute for Health and Care Research (NIHR) to investigate whether anti-tumour necrosis factor (TNF) therapy can reduce or prevent post operative delirium/cognitive deficit.